Collegium Pharmaceutical, Inc.COLLNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank92
5Y CAGR-1.9%
Studio
Year-over-Year Change

Price-to-earnings ratio

5Y CAGR
-1.9%/yr
Long-term compound
Percentile
P92
Near historical high
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
202523.35+74.7%
202413.36-38.0%
202321.57+168.7%
2022-31.39-444.0%
20219.13-64.6%
202025.76+185.0%
2019-30.30-110.0%
2018-14.43-93.3%
2017-7.46-86.0%
2016-4.01-